Back
Novo Nordisk AS Vs. Genfit SA Industry Stock Comparison
Sell
35
NVO
Novo Nordisk AS
Last Price:
110.04
Seasonality Move:
7.98%
Buy
66
GNFT
Genfit SA
Last Price:
5.80
Seasonality Move:
20.08%
Sell
35
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $109.72. The Score for NVO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Genfit SA (GNFT)
is a Buy
Is Genfit SA a Buy, Sell or Hold?
- The current Genfit SA [GNFT] share price is $5.76. The Score for GNFT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- GNFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $109.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
GNFT Stock Price Chart
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.42 | Sell |
| Relative Strength Index (14 RSI): | 26.63 | Sell |
| Chaikin Money Flow: | -3321918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.06 - 118.54) | Sell |
| Bollinger Bands (100): | (120.25 - 140.23) | Sell |
GNFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 54.63 | Buy |
| Chaikin Money Flow: | -799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.4 - 6) | Buy |
| Bollinger Bands (100): | (3.92 - 5.34) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.31 | Sell |
| 20-day SMA: | 115.56 | Sell |
| 50-day SMA: | 124.03 | Sell |
| 200-day SMA: | 128.23 | Sell |
| 8-day EMA: | 112.48 | Sell |
| 20-day EMA: | 115.49 | Sell |
| 50-day EMA: | 121.45 | Sell |
| 200-day EMA: | 122.82 | Sell |
GNFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.68 | Buy |
| 20-day SMA: | 5.78 | Sell |
| 50-day SMA: | 5.08 | Buy |
| 200-day SMA: | 4.25 | Buy |
| 8-day EMA: | 5.76 | Sell |
| 20-day EMA: | 5.66 | Buy |
| 50-day EMA: | 5.25 | Buy |
| 200-day EMA: | 4.45 | Buy |
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.87 per share.
Genfit SA Earnings Growth & GNFT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and a decrease next year of $1.55 per share.
Novo Nordisk AS Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Genfit SA Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||